Related references
Note: Only part of the references are listed.Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial)
Satoshi Sai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Luciana Mosca et al.
DRUG RESISTANCE UPDATES (2021)
A synthetic 2,3-diarylindole induces microtubule destabilization and G2/M cell cycle arrest in lung cancer cells
Bongkotrat Thanaussavadate et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Structure-Activity Relationship Study of Novel 6-Aryl-2-benzoyl-pyridines as Tubulin Polymerization Inhibitors with Potent Antiproliferative Properties
Hao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Microtubule-targeting agents and their impact on cancer treatment
Vladimir Cermak et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2020)
The Mechanism of Tubulin Assembly into Microtubules: Insights from Structural Studies
Marcel Knossow et al.
iScience (2020)
Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review
Eavan C. McLoughlin et al.
PHARMACEUTICALS (2020)
Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indo1-3-yl)-1H-imidazol-4-yl)(3,4,5-trinnethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin
Qinghui Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design, synthesis, and biological evaluation of 1-substituted-2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents
Ling Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
An overview of microtubule targeting agents for cancer therapy
Bensu Karahalil et al.
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2019)
Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead
Emanuela Martino et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Synthesis and biological evaluation of (1-aryl-1H-pyrazol-4-y1) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors
Min'an Zhai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
A fluorescence anisotropy assay to discover and characterize ligands targeting the maytansine site of tubulin
Gregory Menchon et al.
NATURE COMMUNICATIONS (2018)
Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities
Qinghui Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold
Qile Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
Wenlong Li et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Design, Synthesis, and Biological Evaluation of Novel Selenium-Containing Isocombretastatins and Phenstatins as Antitumor Agents
Yanqing Pang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Mechanism of microtubule stabilization by taccalonolide AJ
Yuxi Wang et al.
NATURE COMMUNICATIONS (2017)
Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Lisa Mohr et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Structural Basis of cis- and trans-Combretastatin Binding to Tubulin
Roberto Gaspari et al.
CHEM (2017)
BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe
Zhaoshi Bai et al.
CANCER LETTERS (2017)
Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery
Yuxi Wang et al.
FEBS JOURNAL (2016)
Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation
Andrea E. Prota et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Discovery of Potent Indenoisoquinoline Topoisomerase I Poisons Lacking the 3-Nitro Toxicophore
Daniel E. Beck et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structural Optimization of Indole Derivatives Acting at Colchicine Binding Site as Potential Anticancer Agents
Dong-Jin Hwang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
Andrea E. Prota et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
Andrea E. Prota et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
Andrea E. Prota et al.
SCIENCE (2013)
Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
Jianjun Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Pharmacokinetic Optimization of 4-Substituted Methoxybenzoyl-aryl-thiazole and 2-Aryl-4-benzoyl-imidazole for Improving Oral Bioavailability
Chien-Ming Li et al.
DRUG METABOLISM AND DISPOSITION (2011)
Discovery of 4-Substituted Methoxybenzoyl-aryl-thiazole as Novel Anticancer Agents: Synthesis, Biological Evaluation, and Structure-Activity Relationships
Yan Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Microtubule targeting agents: Basic mechanisms of multidrug resistance (MDR)
AT Fojo et al.
SEMINARS IN ONCOLOGY (2005)
Structural basis for the regulation of tubulin by vinblastine
B Gigant et al.
NATURE (2005)
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
RBG Ravelli et al.
NATURE (2004)
The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity
DE Pryor et al.
BIOCHEMISTRY (2002)
Share Paper
